NYSE:ELN - Elan Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Elan Corporation Ltd (Elan), formerly Elan Corporation, plc, is a biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases. On February 6, 2013, the Company announced that it has entered into an asset purchase agreement with Biogen Idec to transfer to Biogen Idec all Tysabri IP and other assets related to Tysabri. As of 31 December 2012, there were approximately 72,700 Receive ELN News and Ratings via Email Sign-up to receive the latest news and ratings for ELN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNYSE:ELN Previous Symbol CUSIPN/A CIK737572 Webwww.elan.com Phone+353-1-7094000Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Elan (NYSE:ELN) Frequently Asked Questions What is Elan's stock symbol? Elan trades on the New York Stock Exchange (NYSE) under the ticker symbol "ELN." Has Elan been receiving favorable news coverage? Media stories about ELN stock have trended positive this week, InfoTrie Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Elan earned a coverage optimism score of 2.1 on InfoTrie's scale. They also assigned media stories about the biotechnology company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the next several days. What other stocks do shareholders of Elan own? Based on aggregate information from My MarketBeat watchlists, some companies that other Elan investors own include La Jolla Pharmaceutical (LJPC), Sarepta Therapeutics (SRPT), Blackstone Group (BX), Starbucks (SBUX), MGM Resorts International (MGM), Visa (V), Home Depot (HD), Altaba (AABA), Nokia Oyj (NOK) and Gilead Sciences (GILD). How do I buy shares of Elan? Shares of ELN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Elan's official website? The official website for Elan is http://www.elan.com. How can I contact Elan? Elan's mailing address is Treasury Building Grand Canal Street Lower, DUBLIN, 2, Ireland. The biotechnology company can be reached via phone at +353-1-7094000. MarketBeat Community Rating for Elan (NYSE ELN)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 85 (Vote Outperform)Underperform Votes: 106 (Vote Underperform)Total Votes: 191MarketBeat's community ratings are surveys of what our community members think about Elan and other stocks. Vote "Outperform" if you believe ELN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/24/2019 by MarketBeat.com StaffFeatured Article: Do back-end load funds outperform no-load funds?